A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Arch Gen Psychiatry 67(8):793-802 (2010) PMID 20679587 PMCID PMC3000408
Existing therapies for bipolar depression have a considerable lag of onset of action. Pharmacological strategies that produce rapid antidepressant effects-for instance, within a few hours or days-would have an enormous impact on patient care and public health.
DOI: 10.1001/archgenpsychiatry.2010.90
Version: za2963e q8za6 q8zbd q8zc5 q8zd5 q8ze5 q8zf3 q8zge